Epitalon

What Epitalon does

Epitalon is a four-amino-acid peptide studied for aging, sleep rhythms and retinal disease. Small human studies mainly come from one research network; longer life remains unproven. Cell telomere changes do not prove a human benefit. Epithalamin is a different pineal extract. Long-term cancer risk and injection safety remain unknown.

• In a tiny study, it changed levels of melatonin, the body's sleep hormone, but did not show better sleep or longer life. (Studied in a trial)
• An older study of eye injections in people with retinitis pigmentosa suggested changes in vision, without modern trial safeguards. (Studied in a trial)
• Its anti-aging claims about telomeres come from lab studies on cells, which cannot show longer life in people. (animal)
• People report taking it for aging; one user reported better sleep, while others felt no effect. (Reported by users)

Uses in the sources

• Small human studies measured melatonin or clock genes; they did not establish a reliable insomnia benefit. (Studied in a trial) (source)
• An older controlled report studied local eye injections for retinitis pigmentosa. (Studied in a trial) (source)
• Users take it for aging goals. Human lifespan extension has not been shown for synthetic Epitalon. (Reported by users) (source)

Epitalon dosage

Typical reported dose: 1 mg once a day for 20 days

• 10 mcg IM for 10 days: 10 mcg once daily for 10 days daily, into muscle. Studied in a trial. Studied in: Older adults aged 60–79 in a small hormone study. (source)
• Sublingual 0.5 mg/day for 20 days: 0.5 mg/day total; three sprays twice daily daily total, divided into two spray sessions, under the tongue. Studied in a trial. Studied in: Women with low melatonin metabolite, mainly night-shift workers. (source)
• Authors’ proposed repeat IM courses: 10 mcg daily for 10 days per course daily during each course, into muscle. Clinician-published. Studied in: Older adults in a developer-authored clinical paper. (source)
• Reported 1 mg for 20 days: 1 mg daily for 20 days daily, under the skin. Reported by users, occasional report. Studied in: Adults reporting personal use online. (source)
• Reported 10 mg/day, single or split: 10 mg/day, once or as 5 mg twice daily daily, once or divided twice, under the skin. Reported by users, occasional report. Studied in: Adults reporting personal use online. (source)
• Reported 10 mg on five spaced days: 10 mg SC on days 1, 5, 9, 13 and 17 every fourth day for five doses, under the skin. Reported by users, rare report. Studied in: Adults reporting personal use online. (source)

Highest studied: 10 mcg IM daily in the verified human report..

These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.

Work out syringe units with the dosing calculator

How to mix Epitalon

Comes as: Freeze-dried powder vials in community use, Sublingual spray used in a small human trial.

Mixed with: Bacteriostatic water is community-reported. The IM study used saline; that does not validate home injection mixtures..

Common vial sizes: 10, 20, 25, 50 mg. Common water amounts: 2 mL.

• One report used 10 mg with 2 mL water. Actual dose depends on verified vial content, not the syringe markings alone.
• Preservative-containing water does not sterilize contaminated peptide powder.
• Free base, acetate and modified analogues may differ. Do not transfer a storage claim between formulations.
• A spray trial is not a recipe for making nasal or sublingual products from injection powder.

Before mixing: Community users store vials cold. FDA describes limited stability information; no shelf life is established for an unknown vial.

After mixing: Users report refrigeration. No validated home-mixed beyond-use period was found; old stored vials are not proof of potency or sterility.

Epitalon side effects and risks

Reported side effects

• Sleep disruption, activation or anxiety: Anecdotal reports; no denominator or confirmed causality., moderate. Stop and seek review if symptoms persist or worsen. (source)
• Immune reaction to an injection: FDA identifies potential risk; no reliable human incidence., serious (source)
• Injection-related infection: No Epitalon specific incidence available., serious (source)
• Long-term cancer effects, unresolved: Mechanistic concern, not an established human adverse event rate., serious (source)

Stop and get help if

• Trouble breathing, throat or tongue swelling, or collapse: Stop use and call emergency services now.
• Fever with spreading injection-site redness, confusion or fast breathing: Seek urgent emergency care for possible severe infection.

Who should avoid it

• pregnant: No human pregnancy safety data. Precautionary exclusion.
• breastfeeding: Milk transfer and infant effects are unknown. Precautionary exclusion.
• tryingToConceive: Fertility effects and a safe washout interval are unknown. Precautionary exclusion.
• under18: Child safety is unestablished. Small reports do not establish a safe pediatric dose.
• kidneyDisease: Human clearance and dose adjustment in kidney disease are unknown.
• liverDisease: Human clearance and dose adjustment in liver disease are unknown.
• psychiatricCondition: Sleep disruption or agitation may worsen existing symptoms. Human psychiatric safety is untested.
• seizureDisorder: Seizure safety and interactions with seizure medicines have not been established.
• other: Avoid re-exposure after a serious allergic reaction.
• testedAthlete: Treat as prohibited under WADA S0. This applies the class rule; neither peptide is named.
• bleedingDisorder: Needle injections can cause bleeding or a hematoma. This is a procedure risk.
• activeCancer: Precautionary exclusion: telomere-maintenance effects in cancer cells raise concern. Human cancer risk is unknown.
• cancerHistory: Discuss with the oncology team. No human study establishes recurrence risk or long-term cancer safety.

Interactions

• Anticoagulants during intramuscular injections: IM injections can cause bruising or hematoma. A peptide-specific drug interaction has not been studied.
• Insulin and sulfonylureas: No human interaction study or dose-adjustment rule was found. Do not infer a need to change diabetes medicines.
• Melatonin and sleep medicines: Effects on sleep timing may overlap. No human combination or drug-absorption study establishes an interaction or adjustment rule.
• Other experimental peptides: No controlled combination safety evidence found. Sleep disruption is reported; multiple drugs obscure the cause.

Product quality risks

• A 2015 analysis identified Epitalon in two illegal preparations. Identity alone did not establish correct dose, sterility or safety.
• Unapproved injections can contain the wrong drug, the wrong amount, microbes or bacterial toxins called endotoxin.
• A research-only label, clear solution or high purity percentage does not establish injection quality.

What to expect

A small night-shift-worker study used a sublingual Epitalon spray twice daily for 20 days; it measured body-clock gene activity.

Four human reports cover about three participant groups. Two night-shift reports likely reuse participants; longer human life is unproven.

Key studies

• Retinitis pigmentosa: local eye injections: An old controlled report suggests visual changes but lacks modern trial safeguards. (source)
• Older adults: 10 mcg IM course: A tiny IM study changed melatonin levels without showing better sleep or longer life. (source)
• Night-shift workers: sublingual spray: A small biomarker trial does not establish insomnia treatment. (source)
• Night-shift workers: companion gene report: A related report shows gene-expression changes after sublingual exposure. (source)
• Telomerase in human fibroblasts: The central telomerase claim began as a cell-culture finding. (source)
• Cultured cells beyond division limit: A culture result cannot establish human longevity. (source)

Epitalon FAQ

• Is Epitalon FDA-approved? No. Epitalon acetate: limited to subcutaneous, intramuscular forms. Intermittent courses only. The October 30, 2026 Federal Register describes a nonbinding draft interim HHS 503A enforcement policy, with public comment invited. It is conditional on eligible state-licensed pharmacies, federal facilities or licensed physicians, a patient-specific prescription, a single active ingredient, specified identity and route, qualified manufacturing, lot testing, reporting and labeling conditions. It is not FDA drug approval, a final 503A listing or general authorization to supply research products.
• How do people take it? Under the skin, daily. 20 days. Source: reported by users, not an established dose.
• What's the difference between Epitalon and Pinealon? Epitalon: a peptide with telomerase effects in cells, but no proof that people live longer. Pinealon: a peptide with unproven brain benefits and no established injection dose. Why people pair them: users pair them for sleep timing and aging goals.
• Can I take it with Pinealon? Users pair them for sleep timing and aging goals. No controlled combination trial found; worsened sleep is reported. Source: reported by users. Ask a doctor before combining anything.
• Is it banned in sport? Yes. It is banned in and out of competition (WADA 2026). Neither peptide is named. S0 covers pharmacological substances without therapeutic approval; this classification applies that rule.
• How long does a mixed vial last? Users report refrigeration. No validated home-mixed beyond-use period was found; old stored vials are not proof of potency or sterility.